Loading stock data…
CLB
$14.07-0.58 (-3.96%)
Market ClosedLast close May 1
Core Laboratories Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Core Laboratories Inc. in the Energy sector is trading at $14.07. The stock is currently 31% below its 52-week high of $20.36, remaining 6.8% below its 200-day moving average. Technical signals show neutral RSI of 30 and bearish MACD signal, explaining why CLB maintains its current current market pressure. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Oversold momentum (RSI 30) — potential for technical mean-reversion
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
XOMCVXCOP
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$14.07
Potential Downside
25.3%
Whystock Fair Value$10.51
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus3 analysts
Hold
Mean target$16.33+16.1%
Range$12.00 – $22.00
Fundamentals
Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segment...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$794.37M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
27.08
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.16
Div Yield
Strong income play. Yield provides a meaningful total return floor.
23.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
11.14%
Volume
Today's trading volume
919,714
Recent News
Why Core Laboratories (CLB) Shares Are Sliding Today
Shares of oilfield services company Core Laboratories (NYSE:CLB) fell 7.4% in the morning session after the company reported disappointing first-quarter 2026 financial results, with both earnings and revenue falling well short of expectations.
CLB Q1 Deep Dive: Geopolitical Uncertainty and Weather Disruptions Pressure Margins
Oilfield services company Core Laboratories (NYSE:CLB) reported Q1 CY2026 results exceeding the market’s revenue expectations, but sales fell by 1.4% year on year to $121.8 million. Its non-GAAP profit of $0.06 per share was 45.5% below analysts’ consensus estimates.
Core Laboratories Q1 Earnings Call Highlights
Core Laboratories (NYSE:CLB) executives said first-quarter 2026 results were significantly affected by geopolitical and weather-related disruptions, with the escalation of military conflict in the Middle East creating meaningful project delays, halting some hydrocarbon production, and disrupting mar
Core Laboratories N.V. Q1 2026 Earnings Call Summary
Moby summary of Core Laboratories N.V.'s Q1 2026 earnings call
Core Laboratories’s (NYSE:CLB) Q1 CY2026: Beats On Revenue
Oilfield services company Core Laboratories (NYSE:CLB) announced better-than-expected revenue in Q1 CY2026, but sales fell by 1.4% year on year to $121.8 million. Its GAAP loss of $0.02 per share was significantly below analysts’ consensus estimates.